A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
X-linked recessive myotubular myopathy (MTM1) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. We have restricted the candidate region to 280 kb and characterized two candidate genes using positional cloning strategies. The presence of frameshift or missense mutations (of which two are new mutations) in seven patients proved that one of these genes is indeed implicated in MTM1. The protein encoded by the MTM1 gene is highly conserved in yeast, which is surprising for a muscle specific disease. The protein contains the consensus sequence for the active site of tyrosine phosphatases, a wide class of proteins involved in signal transduction. At least three other genes, one located within 100 kb distal from the MTM1 gene, encode proteins with very high sequence similarities and define, together with the MTM1 gene, a new family of putative tyrosine phosphatases in man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The XLMTM is caused by mutations in the myotubularin 1 (MTM1) gene, located at Xq28.31”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [31]
In the citing paper
“Furthermore, mounting evidence shows that autophagy is regulated by distinct mechanisms in different cell types [11–26], and these cell type-specific mechanisms underlie the differential vulnerability of separate tissues to autophagy mutations, resulting in heterogenous manifestations of disease.”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“For instance, centronuclear myopathy is caused by mutations in the genes encoding MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“These loss-of-function mutations prevent these enzymes from metabolizing phosphoinositides required for autophagy, thereby disinhibiting autophagy flux and muscle atrophy [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans
Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., et al. (1994) · Nature · doi:10.1038/368032a0 · Cited by 1,465
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationProtein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes
Fischer, E. H., Charbonneau, H., & Tonks, N. K. (1991) · Science · doi:10.1126/science.1650499 · Cited by 956
Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach.
Uberbacher, E. C., & Mural, R. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11261 · Cited by 652
Sigma factors from E. coli, B. subtilis, phage SP01, and phage T4 are homologous proteins
Gribskov, M., & Burgess, R. R. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.16.6745 · Cited by 445
Hormones, Growth Factors, and Myogenic Differentiation
Florini, J. R., Ewton, D. Z., & Magri, K. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001221 · Cited by 423
Exon amplification: a strategy to isolate mammalian genes based on RNA splicing.
Buckler, A. J., Chang, D. D., Graw, S. L., Brook, J. D., Haber, D. A., Sharp, P. A., & Housman, D. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.4005 · Cited by 420
Research works printed but not linked: 1
- Lanfranchi, G. et al. Identification of 4,370 expressed sequence tags (ESTs) from a 3′-end specific cDNA library of human skeletal muscle by DNA sequencing and fitter hybridization. Genome Res. (in the press).
Cited by
Items 101–200 of 654
A natural history study of X-linked myotubular myopathy
Amburgey, K., Tsuchiya, E., de Chastonay, S., Glueck, M., Alverez, R., Nguyen, C. É., Rutkowski, A., Hornyak, J. E., Beggs, A. H., & Dowling, J. J. (2017) · Neurology · doi:10.1212/wnl.0000000000004415 · Cited by 119
“X-linked myotubular myopathy (MTM) is a neuromuscular disorder caused by mutations in the myotubularin (MTM1) gene.(1) It is a rare condition (estimated at 1:50,000 male births) associated with substantial morbidities and early mortality.”
BackgroundAntisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
Tasfaout, H., Buono, S., Guo, S., Kretz, C., Messaddeq, N., Booten, S. L., Greenlee, S., Monia, B. P., Cowling, B. S., & Laporte, J. (2017) · Nature Communications · doi:10.1038/ncomms15661 · Cited by 114
Self-citationX-Linked Myotubular and Centronuclear Myopathies
Pierson, C. R., Tomczak, K., Agrawal, P., Moghadaszadeh, B., & Beggs, A. H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000171653.17213.2e · Cited by 114
“XLMTM is an X-linked disorder of congenital onset that is caused by MTM1 mutations (15).”
BackgroundInfluentialCowling, B. S., Toussaint, A., Amoasii, L., Koebel, P., Ferry, A., Davignon, L., Nishino, I., Mandel, J., & Laporte, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.054 · Cited by 119
Self-citationBerger, P., Berger, I., Schaffitzel, C., Tersar, K., Volkmer, B., & Suter, U. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi473 · Cited by 121
“The founding member, myotubularin, is the disease-causing gene in X-linked myotubular myopathy (7).”
BackgroundMechanistic Studies on Protein Tyrosine Phosphatases
Zhang, Z. (2003) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(03)01006-7 · Cited by 128
PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models
Sabha, N., Volpatti, J. R., Gonorazky, H., Reifler, A., Davidson, A. E., Li, X., Eltayeb, N. M., Dall’Armi, C., Di Paolo, G., Brooks, S. V., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86841 · Cited by 106
“We found that while Pik3c3 deletion Myotubular myopathy (MTM) is a devastating pediatric neuromuscular disorder of phosphoinositide (PIP) metabolism resulting from mutations of the PIP phosphatase MTM1 for which there are no treatments.”
BackgroundInfluentialTargeting the PTPome in human disease
Tautz, L., Pellecchia, M., & Mustelin, T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.157 · Cited by 118
“Examples of the former mechanism include Lafora’s epilepsy, which is caused by loss of a small PTP with a glycogen-binding domain [62], termed laforin [63], and an X-linked muscle dystrophy caused by loss of a phosphoinositide-specific PTP called myotubularin [64].”
BackgroundThe Myotubularin Family of Lipid Phosphatases
Clague, M. J., & Lorenzo, Ó. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00338.x · Cited by 109
“The prototypical family member, MTM1, was identified as a gene on the X-chromosome, which when mutated leads to a condition known as myotubular myopathy (1).”
BackgroundMochizuki, Y., & Majerus, P. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1333958100 · Cited by 103
Faustino, N. A., & Cooper, T. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.879-887.2005 · Cited by 103
“Several members of this protein family are affected in human diseases such as X-linked myotubular myopathy (MTM1), Charcot–Marie– Tooth type 4B (MTMR2), and congenital DM1 (MTMR1) (3, 6, 27).”
BackgroundInfluentialMolecular and cellular basis of genetically inherited skeletal muscle disorders
Dowling, J. J., Weihl, C. C., & Spencer, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00389-z · Cited by 117
Clinical and histologic findings in autosomal centronuclear myopathy
Jeannet, P., Bassez, G., Eymard, B., Laforêt, P., Urtizberea, J. A., Rouche, A., Guicheney, P., Fardeau, M., & Romero, N. B. (2004) · Neurology · doi:10.1212/01.wnl.0000124388.67003.56 · Cited by 107
Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions
Velichkova, M., Juan, J., Kadandale, P., Jean, S., Ribeiro, I., Raman, V., Stefan, C., & Kiger, A. A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911020 · Cited by 95
“MTM1 is associated with human myotubular myopathy (Laporte et al., 1996), whereas the closely related MTMR2 is associated with Charcot-Marie-Tooth neuropathy (Bolino et al.”
BackgroundNandurkar, H. H., Layton, M., Laporte, J., Selan, C., Corcoran, L., Caldwell, K. K., Mochizuki, Y., Majerus, P. W., & Mitchell, C. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1033097100 · Cited by 99
Self-citationSrivastava, S., Li, Z., Lin, L., Liu, G., Ko, K., Coetzee, W. A., & Skolnik, E. Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3630-3638.2005 · Cited by 101
“MTM1, the founding member of this gene family, is mutated in X-linked myotubular myopathy, and MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) syndrome type 4B (3, 30, 37).”
BackgroundLorenzo, O., Urbé, S., & Clague, M. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03040 · Cited by 94
The structure and regulation of myotubularin phosphatases
Begley, M. J., & Dixon, J. E. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.016 · Cited by 112
Skeletal muscle: molecular structure, myogenesis, biological functions, and diseases
Feng, L., Chen, Z., & Bian, H. (2024) · MedComm · doi:10.1002/mco2.649 · Cited by 121
“188 Myotubularin is a phosphosinositide FIGURE 5 Classification and pathogenic genes of inherited myopathies.”
BackgroundGiaimo, R. D., Riccio, M., Santi, S., Galeotti, C. L., Ambrosetti, D. C., & Melli, M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2941 · Cited by 101
Protein tyrosine phosphatases: dual‐specificity phosphatases in health and disease
Pulido, R., & van Huijsduijnen, R. H. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06250.x · Cited by 111
Autosomal-Recessive Forms of Demyelinating Charcot-Marie-Tooth Disease
Dubourg, O., Azzedine, H., Verny, C., Durosier, G., Birouk, N., Gouider, R., Salih, M. A. M., Bouhouche, A., Thiam, A., Grid, D., et al. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:1-2:75 · Cited by 103
“Myotubularin 1 (MTM1), another member of the myotubularin family, is responsible for X-linked myotubular myopathy (Laporte et al., 1996).”
BackgroundBegley, M. J., Taylor, G. S., Brock, M. A., Ghosh, P., Woods, V. L., & Dixon, J. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510006103 · Cited by 93
Spiegelhalter, C., Tosch, V., Hentsch, D., Koch, M., Kessler, P., Schwab, Y., & Laporte, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009014 · Cited by 83
“[28] and Kazusa human cDNA project) and BIN1 muscle-specifc isoform 8 cDNA (a gift from P.”
BackgroundSelf-citationEndosomal lipid signaling reshapes the endoplasmic reticulum to control mitochondrial function
Jang, W., Puchkov, D., Samsó, P., Liang, Y., Nadler-Holly, M., Sigrist, S. J., Kintscher, U., Liu, F., Mamchaoui, K., Mouly, V., et al. (2022) · Science · doi:10.1126/science.abq5209 · Cited by 100
“Defects in ER shape, mitochondrial morphogenesis, and cellular ATP depletion caused by loss of MTM1 function can explain the observed myofiber hypotrophy and defective sarcoplasmic reticulum organization in animal models of XLCNM (16, 17) and in human patients who often appear undernourished (19, 30, 31).”
BackgroundPTEN: Sometimes Taking It Off Can Be Better than Putting It On
Myers, M. P., & Tonks, N. K. (1997) · The American Journal of Human Genetics · doi:10.1086/301659 · Cited by 94
Chaouch, M., Allal, Y., Sandre‐Giovannoli, A. D., Vallat, J. M., Wahiba, A. E. K., Kassouri, N., Chaouch, A., Sindou, P., Hamadouche, T., Tazir, M., et al. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00196-7 · Cited by 94
Dowling, J. J., Low, S. E., Busta, A. S., & Feldman, E. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq153 · Cited by 87
Lawlor, M. W., & Dowling, J. J. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.08.003 · Cited by 96
Disease-related Myotubularins Function in Endocytic Traffic inCaenorhabditis elegans
Dang, H. T. L., Li, Z., Skolnik, E. Y., & Fares, H. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0605 · Cited by 98
“X-linked myotubular myopathy, a severe congenital disorder characterized by hypotonia and generalized muscle weakness in newborn males, is caused by mutations in MTM1 (Laporte et al., 1996).”
Phosphoinositide Regulation of Integrin Trafficking Required for Muscle Attachment and Maintenance
Ribeiro, I., Yuan, L., Tanentzapf, G., Dowling, J. J., & Kiger, A. A. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001295 · Cited by 95
“myotubular (centronuclear) myopathy (XLMTM, OMIM #310400) characterized by centrally misplaced nuclei in hypotrophic myofibers [9,10].”
BackgroundRobinson, F. L., Niesman, I. R., Beiswenger, K. K., & Dixon, J. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800742105 · Cited by 91
“In addition to MTMR2 and MTMR13, MTM1 and MTMR5 have been shown to play critical roles in mammalian physiology (32, 33).”
BackgroundFirestein, R., Nagy, P. L., Daly, M. E., Huie, P., Conti, M., & Cleary, M. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0212589 · Cited by 97
Böhm, J., Vasli, N., Maurer, M., Cowling, B. S., Shelton, G. D., Kreß, W., Toussaint, A., Prokic, I., Schara, U., Anderson, T. J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003430 · Cited by 97
“Human Genomic DNA was prepared from peripheral blood by routine procedures and sequenced for all coding exons and intron/exon boundaries of MTM1, DNM2, and BIN1 as described elsewhere [1,4,5].”
BackgroundMethodSelf-citationLaporte, J., Blondeau, F., Gansmuller, A., Lutz, Y., Vonesch, J.-L., & Mandel, J.-L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3105 · Cited by 79
Self-citationSET binding factor 1 ( SBF1 ) mutation causes Charcot-Marie-Tooth disease type 4B3
Nakhro, K., Park, J., Hong, Y. B., Park, J. H., Nam, S. H., Yoon, B. R., Yoo, J. H., Koo, H., Jung, S., Kim, H., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829a3421 · Cited by 98
“Mutations in theMTM1 gene encoding another myotubularin-related protein are associated with X-linked myotubular myopathy.(8,9) The MTMR2 protein has a phosphatase domain; however, SBF2 has a pseudophosphatase caused by replacement of a catalytic cysteine residue with leucine.”
BackgroundCharacterization of mutations in fifty North American patients with X-linked myotubular myopathy
Herman, G. E., Kopacz, K., Zhao, W., Mills, P. L., Metzenberg, A. B., & Das, S. (2002) · Human Mutation · doi:10.1002/humu.10033 · Cited by 87
“In 1996, the MTM1 gene was isolated using a positional cloning approach [Laporte et al., 1996].”
Al‐Qusairi, L., Prokic, I., Amoasii, L., Kretz, C., Messaddeq, N., Mandel, J., & Laporte, J. (2013) · The FASEB Journal · doi:10.1096/fj.12-220947 · Cited by 76
Self-citationRomero, N. B., & Clarke, N. F. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00004-6 · Cited by 86
“Some are unexpected causes, for instance the selenoprotein N gene (SEPN1) in multiminicore disease which was first reported in rigid spine with congenital muscular dystrophy, and the myotubularin 1 gene (MTM1), a 30-phosphoinositide phosphatase which causes severe X-linked myotubular myopathy and necklace fiber myopat…”
BackgroundThe LIM Proteins FHL1 and FHL3 Are Expressed Differently in Skeletal Muscle
Morgan, M. J., & Madgwick, A. J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0179 · Cited by 85
Triadopathies: An Emerging Class of Skeletal Muscle Diseases
Dowling, J. J., Lawlor, M. W., & Dirksen, R. T. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0300-3 · Cited by 87
“Patients with MTM1 mutations are said to have myotubular myopathy [43].”
BackgroundGouyon, B. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1499 · Cited by 84
“(15), with translation beginning at the first methionine in the cDNA sequence (12) at bp 55.”
BackgroundMethodBeggs, A. H., Byrne, B. J., De Chastonay, S., Haselkorn, T., Hughes, I., James, E. S., Kuntz, N. L., Simon, J., Swanson, L. C., Yang, M. L., et al. (2018) · Muscle & Nerve · doi:10.1002/mus.26018 · Cited by 83
“Black 2 (5) 1 (1) 3 (3) Asian 1 (3) 1 (1) 2 (2) Unknown 4 (10) 5 (7) 9 (8) Other 8 (20) 12 (17) 20 (18) White, Native American 4 (50) 7 (58) 11 (55)”
Morales, L., Gambhir, Y., Bennett, J., & Stedman, H. H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.009 · Cited by 86
“3,4 The resulting lipid second messenger is involved in endosome traf fi cking, autophagy, desmin fi lament architecture, mitochondrial dynamics, muscle excitation-contraction coupling, and regulation of the ubiquitin-proteasome pathway.”
Phosphoinositide phosphatases in a network of signalling reactions
Bléro, D., Payrastre, B., Schurmans, S., & Erneux, C. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0304-5 · Cited by 93
The genetics of congenital myopathies
Gonorazky, H. D., Bönnemann, C. G., & Dowling, J. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00036-3 · Cited by 92
Chaussade, C., Pirola, L., Bonnafous, S., Blondeau, F., Verca, S. B., Tronchère, H., Portis, F., Rusconi, S., Payrastre, B., Laporte, J., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0261 · Cited by 85
Self-citationThe myotubularin–amphiphysin 2 complex in membrane tubulation and centronuclear myopathies
Royer, B., Hnia, K., Gavriilidis, C., Tronchère, H., Tosch, V., & Laporte, J. (2013) · EMBO reports · doi:10.1038/embor.2013.119 · Cited by 70
“Mutations in the phosphoinositides phosphatase myotubularin (MTM1) lead to a significant decrease of the protein level [2] and cause the X-linked form of CNM, also called myotubular myopathy [3].”
Self-citationWiessner, M., Roos, A., Munn, C. J., Viswanathan, R., Whyte, T., Cox, D., Schoser, B. G. H., Sewry, C. A., Roper, H., Phadke, R., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.024 · Cited by 86
PtdIns5P regulation through evolution: roles in membrane trafficking?
Lecompte, O., Poch, O., & Laporte, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.07.002 · Cited by 81
Self-citationSbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling
Jean, S., Cox, S., Schmidt, E. J., Robinson, F. L., & Kiger, A. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-05-0375 · Cited by 76
“MTMs have been identified with endosomal roles that impact the trafficking of specific surface receptors and adhesion proteins, or cortical remodeling (Kim et al., 2002; Tsujita et al., 2004; Cao et al., 2008; Lee et al., 2010; Silhankova et al., 2010; Velichkova et al., 2010; Ribeiro et al., 2011).”
BackgroundDiagnosis of X‐linked myotubular myopathy by detection of myotubularin
Laporte, J., Kreß, W., & Mandel, J. (2001) · Annals of Neurology · doi:10.1002/ana.1033 · Cited by 80
“Phenotype for P205L is always severe in other patients. bPatient H31 is deleted for all MTM1 gene by PCR (not shown).”
BackgroundInfluentialSelf-citationPierson, C. R., Dulin-Smith, A. N., Durban, A. N., Marshall, M. L., Marshall, J. T., Snyder, A. D., Naiyer, N., Gladman, J. T., Chandler, D. S., Lawlor, M. W., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr512 · Cited by 79
“which encodes a phosphoinositide lipid phosphatase called myotubularin (4).”
Muscle ankyrin repeat proteins: their role in striated muscle function in health and disease
Kojić, S., Radojkovic, D. P., & Faulkner, G. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.643857 · Cited by 85
Phosphoinositides in autophagy: current roles and future insights
Palamiuc, L., Ravi, A., & Emerling, B. M. (2020) · The FEBS Journal · doi:10.1111/febs.15127 · Cited by 75
Reducing dynamin 2 (DNM2) rescues DNM2 -related dominant centronuclear myopathy
Buono, S., Ross, J. A., Tasfaout, H., Levy, Y., Kretz, C., Tayefeh, L., Matson, J. E., Guo, S., Kessler, P., Monia, B. P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808170115 · Cited by 76
“In addition to DNM2, the main mutated genes linked with CNM are MTM1, encoding the lipid phosphatase myotubularin, for the X-linked form (OMIM 310400) (17); and BIN1, encoding the membrane remodeling protein amphiphysin 2 for autosomal forms (OMIM 255200) (18, 19).”
BackgroundSelf-citationThe dynamic proliferation of CanSINEs mirrors the complex evolution of Feliforms
Walters-Conte, K., Johnson, D. L., Johnson, W. E., O’Brien, S. J., & Pecon‐Slattery, J. (2014) · BMC Evolutionary Biology · doi:10.1186/1471-2148-14-137 · Cited by 76
“For example, alterations of fur color [31], muscular disorders [32,33] and body size diversity [34,35] in Canidae are correlated with SINE insertions associated respectively with SILV, PTPLA and IGF1 .”
Fetal akinesia: review of the genetics of the neuromuscular causes: Table 1
Ravenscroft, G., Sollis, E., CHARLES, A. K., North, K. N., Baynam, G. S., & Laing, N. G. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100211 · Cited by 75
Judson, R. N., Gray, S. R., Walker, C., Carroll, A. M., Itzstein, C., Lionikas, A., Zammit, P. S., De Bari, C., & Wackerhage, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059622 · Cited by 69
“Genetic linkage studies have found X-linked recessive centronuclear myopathy is caused by mutations in the gene MTM1 (encodes protein Myotubularin) [63], whereas autosomal dominant and recessive forms are caused by mutations in DNM2 (encodes protein Dynamin 2) [64] and BIN1 (encodes protein Amphiphysin 2) [65] genes r…”
BackgroundThe structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis
Hsu, F., & Mao, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.015 · Cited by 71
Defective Membrane Remodeling in Neuromuscular Diseases: Insights from Animal Models
Cowling, B. S., Toussaint, A., Muller, J., & Laporte, J. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002595 · Cited by 76
“MTM1 is mutated in the X-linked, most severe form of CNM [2,3].”
BackgroundSelf-citationAnalysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3
Lorenzo, O., Urbé, S., & Clague, M. J. (2005) · Journal of Cell Science · doi:10.1242/jcs.02325 · Cited by 70
“It was identified as a gene on the X chromosome, which when mutated, led to a defect in myotube maturation and a condition known as myotubular myopathy (Laporte et al., 1996).”
BackgroundSrivastava, S., Choudhury, P., Li, Z., Liu, G., Nadkarni, V., Ko, K., Coetzee, W. A., & Skolnik, E. Y. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0763 · Cited by 69
“MTMR2 and MTMR13 were identified as genes mutated in a subset of patients with Charcot Marie Tooth Syndrome type 4B (Laporte et al., 1996; Bolino et al., 2000).”
BackgroundGenetic Analysis of the Myotubularin Family of Phosphatases in Caenorhabditis elegans
Xue, Y., Fares, H., Grant, B., Li, Z., Rose, A. M., Clark, S. G., & Skolnik, E. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303259200 · Cited by 69
Shelton, G. D., Rider, B. E., Child, G., Tzannes, S., Guo, L. T., Moghadaszadeh, B., Troiano, E. C., Haase, B., Wade, C. M., & Beggs, A. H. (2015) · Skeletal Muscle · doi:10.1186/s13395-014-0025-3 · Cited by 69
“An important, well-defined sub-group of CNMs is X-linked myotubular myopathy (XLMTM) associated with mutations in the MTM1 gene [7].”
BackgroundSewry, C. A., Jimenez-Mallebrera, C., & Muntoni, F. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830f93c7 · Cited by 73
Manini, A., Abati, E., Nuredini, A., Corti, S. P., & Comi, G. P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.814174 · Cited by 83
“However, in June 2021 Audentes Therapeutics reported the death of three patients affected by X-linked myotubular myopathy (XLMTM), who received the highest AAV dose ever used in humans (3 x 1014 vg/kg) in the context of the ASPIRO clinical trial (NCT03199469), aimed at evaluating safety and efficacy of AT132, an AAV8-…”
BackgroundComprehensive Expression Profiles of Genes for Protein Tyrosine Phosphatases in Immune Cells
Arimura, Y., & Yagi, J. (2010) · Science Signaling · doi:10.1126/scisignal.2000966 · Cited by 72
“Since the first report that mutations inMTM1 cause X-linked myotubular myopathy in humans (15), the involvement of many PTPs in diseases has been identified.”
BackgroundDiverse roles of the actin cytoskeleton in striated muscle
Kee, A. J., Gunning, P. W., & Hardeman, E. C. (2009) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-009-9193-x · Cited by 72
“In humans, the genes that are mutated in CNM have roles in vesicle trafficking, and membrane structure and function (myotubulin, dynamin-2, amphiphysin-2, ryanodine receptor) indicating disruption to membrane function is the cause of CNM (Bitoun et al. 2009; Cao et al. 2008; Jungbluth et al. 2008; Laporte et al. 1996).”
BackgroundClinical features and molecular genetics of hereditary peripheral neuropathies
Kuhlenb�umer, G., Young, P., H�nermund, G., Ringelstein, B. E., & St�gbauer, F. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0946-3 · Cited by 73
“Mutations in the myotubularin gene (MTM1), which is the first cloned member of this gene family, cause X-linked recessive myotubulary myopathy [112].”
BackgroundMyotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo
Amoasii, L., Hnia, K., Chicanne, G., Brech, A., Cowling, B. S., Mueller, M. M., Schwab, Y., Koebel, P., Ferry, A., Payrastre, B., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.118505 · Cited by 71
“The X-linked form of CNM (XLCNM) is associated with mutations in the MTM1 gene encoding myotubularin, a ubiquitously expressed lipid phosphatase that acts on bioactive phosphoinositide (PI) second messengers (Laporte et al., 1996).”
BackgroundSelf-citationBiancalana, V., Scheidecker, S., Miguet, M., Laquerrière, A., Romero, N. B., Stojkovic, T., Neto, O. L. A., Mercier, S., Voermans, N. C., Tanner, L. M., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1748-0 · Cited by 75
Self-citationTamoxifen therapy in a murine model of myotubular myopathy
Maani, N., Sabha, N. S., Rezai, K., Ramani, A. K., Groom, L. A., Eltayeb, N., Mavandadnejad, F., Pang, A., Russo, G., Brudno, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07057-5 · Cited by 75
Congenital Muscular Dystrophy and Congenital Myopathy
Butterfield, R. J. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000792 · Cited by 71
Tanner, S. M., Ørstavik, K. H., Kristiansen, M. B., Lev, D., Lerman‐Sagie, T., Sadeh, M., & Liechti‐Gallati, S. (1999) · Human Genetics · doi:10.1007/s004390050943 · Cited by 70
“However, the identification of more than 100 different pathogenetic MTM1 mutations (e.g., Laporte et al. 1996, 1997; de Gouyon et al. 1997; Tanner et al. in press) underlines a primary role for this gene in the etiology of this disorder.”
BackgroundWANTED – Dead or alive: Myotubularins, a large disease-associated protein family
Raess, M. A., Friant, S., Cowling, B. S., & Laporte, J. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.09.001 · Cited by 68
Self-citationCatteruccia, M., Fattori, F., Codemo, V., Ruggiero, L., Maggi, L., Tasca, G. A., Fiorillo, C., Pane, M., Berardinelli, A. L., Verardo, M., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.12.009 · Cited by 68
“CNMs are generally clinically milder than the X-linked neonatal forms associated with mutations in myotubularin gene (MTM1MIM; # 300415) [2], and the autosomal recessive (AR) forms related to mutations in the membrane-bending protein amphiphysin 2 (BIN1; MIM# 601248) [3].”
BackgroundLawlor, M. W., Read, B., Edelstein, R., Yang, N. J., Pierson, C. R., Stein, M. J., Wermer-Colan, A., Buj‐Bello, A., Lachey, J. L., Seehra, J. S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.035 · Cited by 69
Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1
Swan, L. E., Tomasini, L., Pirruccello, M., Lunardi, J., & Camilli, P. V. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914658107 · Cited by 68
“Two human diseases are caused by mutations in an enzyme that selectively dephosphorylates the inositol ring at the 5′ position, using phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3], two phosphoinositides concentrated in the plasma membrane, as its preferred…”
BackgroundLaporte, J., Kioschis, P., Hu, L., Kretz, C., Carlsson, B., Poustka, A., Mandel, J., & Dahl, N. (1997) · Genomics · doi:10.1006/geno.1997.4662 · Cited by 67
Self-citationBöhm, J., Yiş, U., Ortaç, R., Çakmakçı, H., Kurul, S. H., Dırık, E., & Laporte, J. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-35 · Cited by 72
“Myotubularin (MTM1) is mutated in XLCNM [5] and belongs to a large family of ubiquitously expressed phosphoinositide phosphatases implicated in intracellular vesicle trafficking [6-8].”
BackgroundSelf-citationTiosano, D., Baris, H. N., Chen, A., Hitzert, M. M., Schueler, M., Gulluni, F., Wiesener, A., Bergua, A., Mory, A., Copeland, B., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008088 · Cited by 65
“These include Charcot-Marie-Tooth type 4J ( FIG4 ) [10,11], Centronuclear X-linked myopathy ( MTM1 ) [12], and primary immunodeficiency ( PIK3CD ) [13,14], among others.”
BackgroundPTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench
Wishart, M. J., Taylor, G. S., Slama, J. T., & Dixon, J. E. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00195-2 · Cited by 73
Congenital myopathies and congenital muscular dystrophies
Tubridy, N. J., Fontaine, B., & Eymard, B. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200110000-00005 · Cited by 66
Long-term effects of systemic gene therapy in a canine model of myotubular myopathy
Elverman, M., Goddard, M. A., Mack, D., Snyder, J. M., Lawlor, M. W., Meng, H., Beggs, A. H., Buj‐Bello, A., Poulard, K., Marsh, A. P., et al. (2017) · Muscle & Nerve · doi:10.1002/mus.25658 · Cited by 65
“The disease is caused by mutation of the MTM1 gene,(4,5) and affected boys develop severe weakness of skeletal muscles due to a deficiency of the protein myotubularin.(4,6) XLMTM presents at birth as marked hypotonia and respiratory impairment and is often fatal in the first year of life.”
BackgroundMyotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models
Dowling, J. J., Joubert, R., Low, S. E., Durban, A. N., Messaddeq, N., Li, X., Dulin-Smith, A. N., Snyder, A. D., Marshall, M. L., Marshall, J. T., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009746 · Cited by 65
“Currently, mutations in four genes are associated with CNM: dynamin-2 (DNM2) (Bitoun et al., 2005), bridging integrator 1 (BIN1) (Nicot et al., 2007), the skeletal muscle ryanodine receptor (RYR1) (Wilmshurst et al., 2010) and myotubularin (MTM1) (Laporte et al., 1996).”
BackgroundZou, J., Zhang, C., Marjanovic, J., Kisseleva, M. V., Majerus, P. W., & Wilson, M. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207021109 · Cited by 63
“Mutations in myotubularin cause myotubular myopathy (7), and mutations in myotubularin-related protein 2 (MTMR2) and MTMR13 cause a form of Charcot Marie Tooth disease type 4B, a demyelinating neurodegenerative disorder (8, 9).”
BackgroundSingle Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice
Tasfaout, H., Lionello, V. M., Kretz, C., Koebel, P., Messaddeq, N., Bitz, D., Laporte, J., & Cowling, B. S. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.008 · Cited by 67
Self-citationCaenorhabditis elegans Myotubularin MTM-1 Negatively Regulates the Engulfment of Apoptotic Cells
Zou, W., Lu, Q., Zhao, D., Li, W., Mapes, J., Xie, Y., & Wang, X. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000679 · Cited by 58
“(CMT4B1) [18–20].”
What’s new in congenital myopathies?
North, K. N. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.04.002 · Cited by 63
“Nevertheless, disorders such as cap disease, myosin storage myopathy and sarcotubular myopathy were once classified as ‘‘possible congenital myopathies” since only a few cases were reported – and the genes have since been identified by sequencing of candidate genes suggested by the ultrastructural features on muscle b…”
InfluentialPhosphatase-Dead Myotubularin Ameliorates X-Linked Centronuclear Myopathy Phenotypes in Mice
Amoasii, L., Bertazzi, D. L., Tronchère, H., Hnia, K., Chicanne, G., Rinaldi, B., Cowling, B. S., Ferry, A., Klaholz, B. P., Payrastre, B., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002965 · Cited by 63
Self-citationRomero-Suarez, S., Shen, J., Brotto, L., Hall, T., Mo, C., Valdivia, H. H., Andresen, J., Wacker, M., Nosek, T. M., Qu, C.-K., et al. (2010) · Aging · doi:10.18632/aging.100190 · Cited by 61
“Importantly, loss-of-function mutations in several MTMR phosphatases (MTM1, MTMR2, and MTMR13) have been identified in genetic conditions, namely Xlinked myotubular myopathy (a muscle degenerative disease that shares some similarities with sarcopenia) and Type-4B Charcot-Marie-Tooth disease (a neurodegenerative condit…”
BackgroundGómez, R., Cowling, B. S., & Laporte, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111377 · Cited by 68
“Clinical presentation and inheritance are heterogenous and can be classified into three main groups: the most severe X-linked CNM (XLMTM, myotubular myopathy) caused by mutations in MTM1 encoding myotubularin (MTM1) [3]; autosomal dominant CNM (ADCNM) caused by dominant mutations in DNM2 encoding dynamin 2 (DNM2) [4]…”
BackgroundSelf-citationTrésaugues, L., Silvander, C., Flodin, S., Welin, M., Nyman, T., Gräslund, S., Hammarström, M., Berglund, H., & Nordlund, P. (2014) · Structure · doi:10.1016/j.str.2014.01.013 · Cited by 58
Single gene disorders associated with congenital diaphragmatic hernia
Slavotinek, A. M. (2007) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30125 · Cited by 62
“MTM1 is caused by loss of function mutations in the MTM1 gene at Xq28 [Laporte et al., 1996].”
BackgroundThe progress of AAV-mediated gene therapy in neuromuscular disorders
Aguti, S., Malerba, A., & Zhou, H. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1479739 · Cited by 55
“Xq28, resulting in loss of function of the encoded myotubularin protein [86].”
BackgroundActivation Mechanisms of the VPS34 Complexes
Ohashi, Y. (2021) · Cells · doi:10.3390/cells10113124 · Cited by 67
“Mutations in the MTM1 gene caused a severe form of X-linked congenital myopathy [67].”
BackgroundCongenital myopathies at their molecular dawning
Goebel, H. H. (2003) · Muscle & Nerve · doi:10.1002/mus.10322 · Cited by 61
Bartsch, O., Kreß, W., Wagner, A., & Seemanová, E. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015284 · Cited by 60
“The myotubularin gene resides on proximal Xq28 (Thomas et al., 1990; Darnfors et al., 1990; Lehesjoki et al., 1990; Dahl et al., 1995; Hu et al., 1996a) and was recently cloned and analysed (Laporte et al., 1996 and 1998).”
Background
Metadata
- Authors
- Laporte, J., Hu, L. J., Kretz, C., Mandel, J.-L., Kioschis, P., Coy, J. F., Klauck, S. M., Poustka, A., & Dahl, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- German Cancer Research Center (DE)
- Uppsala University (SE)
- Venue
- Nature Genetics
- Published
- 1996-06
- Volume
- 13
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1984366092
- Cited by
- 639
- References
- 51
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 26 · 2018: 25 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 28 · 2013: 35 · 2012: 26
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- X-linked myotubular myopathy, MTM1 gene, positional cloning, frameshift mutation, missense mutations, yeast homolog, hypotonia, signal transduction, conserved protein families
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cloning, Molecular, Genes, Fungal, Humans, Genetic Linkage, Molecular Sequence Data, Muscle Hypotonia, Muscular Diseases, Mutation, Saccharomyces cerevisiae, Tissue Distribution, X Chromosome, Protein Tyrosine Phosphatases, Conserved Sequence, Caenorhabditis elegans, Protein Tyrosine Phosphatases, Non-Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.